Senior Manager, Clinical Quality jobs in United States
cer-icon
Apply on Employer Site
company-logo

Compass Pathways · 4 weeks ago

Senior Manager, Clinical Quality

Compass Pathways plc is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Senior Manager, Clinical Quality is responsible for developing and implementing a risk-based GCP audit program, ensuring compliance with regulations, and supporting regulatory inspections.

BiotechnologyHealth CareLife ScienceMental HealthPersonal HealthWellness
check
Growth Opportunities
badNo H1Bnote

Responsibilities

Provision of GCP QA advice and support to clinical project teams and cross-functional departments to help ensure compliance with applicable regulations and internal quality standards
May act on behalf of the Director, Clinical QA, to provide leadership support and ensure continuity of QA oversight and decision-making
Manage GCP audits of sites, documents, databases, vendors, or internal systems in compliance with GCP and Compass quality standards
Coordinate activities of external auditors, during the preparation, conduct and reporting of GCP audits
Support, and conduct when required, risk-based audits of clinical trial sites, both internally and those managed by CROs (Contract Research Organizations), vendors and internal systems ensuring adherence to GCP guidelines, protocols, and regulatory standards
Support the preparation of comprehensive audit reports, identifying potential issues and recommending corrective actions for internal teams and collaborating with CROs to implement necessary changes
Work closely with internal teams to ensure alignment with GCP expectations to address findings and action items from audits
When required, lead investigations into significant quality issues, facilitate identification of root cause and development of appropriate corrective and preventive actions; track actions and confirm effectiveness
Proactively assess compliance issues and risks; serve as the expert GCP consultant for issue management & issue escalation
Support partner organizations as necessary to ensure that timelines are met, milestones and products are delivered on schedule, and any excursions, deviations, investigations, and CAPAs are initiated, addressed, and closed within target timeframes
Support the management of GCP inspections within Compass and at vendors/partners of Compass studies and/or processes, as required
Liaise with regulatory agencies (e.g., FDA, EMA) regarding GCP compliance matters
Stay up-to-date on evolving GCP regulations and best practices in clinical trial audit methodology
Participate in the development and implementation of training programs for clinical trial staff, both internal and at CRO partners, on GCP and regulatory compliance
Contribute to the development and review of standard operating procedures (SOPs)

Qualification

GCP auditingClinical trial operationsGCP guidelines knowledgeLeadership skillsProject managementAnalytical skillsCommunication skillsProblem-solving skillsTeamwork

Required

GCP QA professional with broad drug experience which spans all clinical phases (Phase I to IV)
Extensive experience in GCP auditing and clinical trial operations
In-depth knowledge of GCP guidelines (ICH-GCP) and regulatory requirements for clinical trials
Strong understanding of clinical trial design, conduct, and data management
Excellent leadership, communication, and interpersonal skills
Strong analytical and problem-solving skills
Ability to work independently and as part of a team
Excellent project management skills
Alignment with the Compass values

Preferred

Degree in a life science field or a related clinical research area

Company

Compass Pathways

twittertwittertwitter
company-logo
Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.

Funding

Current Stage
Public Company
Total Funding
$421.21M
Key Investors
Hercules CapitalMcQuade Center for Strategic Research and Development
2025-01-10Post Ipo Equity· $150M
2023-08-16Post Ipo Equity· $125M
2023-07-05Post Ipo Debt· $30M

Leadership Team

leader-logo
Kabir Nath
Chief Executive Officer
linkedin
leader-logo
Teri loxam
Chief Financial Officer
linkedin
Company data provided by crunchbase